Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Evaluating the analytical validity of circulating tumor DNA sequencing assays for precision oncology

12 Apr 2021

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Genomics and Diagnostics
Share to Lung Cancer Treatments and Mutations
Share to Renal cell carcinoma treatment

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 33846644
DOI: 10.1038/s41587-021-00857-z

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Evaluating the analytical validity of circulating tumor DNA sequencing assays for precision oncologyPMID 33846644Read ↗

Clinical Circulating Tumor DNA Testing for Precision Oncology.Semantic proximity Read ↗

Reliability of liquid biopsy analysis: an inter-laboratory comparison of circulating tumor DNA extraction and sequencing with different platformsSemantic proximity Read ↗

Utilizing Plasma Circulating Tumor DNA Sequencing for Precision Medicine in the Management of Solid Cancers.Semantic proximity Read ↗

Circulating Tumor DNA Analysis in Patients With Cancer: American Society of Clinical Oncology and College of American Pathologists Joint ReviewSemantic proximity Read ↗

Technical progress in circulating tumor DNA analysis using next generation sequencingSemantic proximity Read ↗

Circulating tumor DNA in advanced solid tumors: Clinical relevance and future directions.Semantic proximity Read ↗

Next-Generation Sequencing of Circulating Tumor DNA for Early Cancer DetectionSemantic proximity Read ↗

Validation and clinical evaluation of a comprehensive circulating tumor DNA assay for genomic profiling in solid tumorsSemantic proximity Read ↗

An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverageSemantic proximity Read ↗

Analytical evaluation of circulating tumor DNA sequencing assays.Semantic proximity Read ↗

Cell-free circulating tumor DNA profiling in cancer managementSemantic proximity Read ↗

Validation of a liquid biopsy assay with molecular and clinical profiling of circulating tumor DNASemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.